moxalactam has been researched along with Acute Kidney Failure in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kojima, R; Suzuki, Y | 1 |
| Clark, J; D'Elia, JA; Hochman, R; Kaldany, A; Miller, DG; Rolla, AR; Thomas, S | 1 |
| Fond, G; Godard, J; Mahul, P; Motin, J; Perrot, D; Reverdy, ME | 1 |
3 other study(ies) available for moxalactam and Acute Kidney Failure
| Article | Year |
|---|---|
[Studies on the nephrotoxicity of aminoglycoside antibiotics and protection from these effects. (2). Protective effect of latamoxef against gentamicin nephrotoxicity].
Topics: Acetylglucosaminidase; Acute Kidney Injury; Animals; Anti-Bacterial Agents; Blood Urea Nitrogen; Gentamicins; Kidney; Kidney Tubular Necrosis, Acute; Male; Moxalactam; Proteinuria; Rats; Rats, Inbred Strains | 1984 |
Coagulopathy associated with the use of cephalosporin or moxalactam antibiotics in acute and chronic renal failure.
Topics: Acute Kidney Injury; Adult; Aged; Blood Coagulation Disorders; Cephalosporins; Female; Humans; Hypoprothrombinemias; Kidney Failure, Chronic; Male; Middle Aged; Moxalactam; Peritoneal Dialysis; Prothrombin Time; Renal Dialysis | 1983 |
[Erythromycin and latamoxef in the initial treatment of diffuse peritonitis with visceral failure].
Topics: Acute Disease; Acute Kidney Injury; Adult; Aged; Drug Therapy, Combination; Erythromycin; Female; Humans; Male; Middle Aged; Moxalactam; Multiple Organ Failure; Peritonitis | 1987 |